Since I have just opened up some Celgene .pdfs for their last quarter, I’ll paste the links below and then throw out a quick 1YPEG that might be a little eye-catching.
Simply looking at Slide 12 from this first link, and using adjusted rather than GAAP EPS numbers as Saul often advocates and the present share price, I see EPS of $7.44 which was growth of 25% Y-o-Y. Today’s closing price was $91.51.
P/E - 91.51 divided by 7.44 = 12.3
EPS growth rate = 25%
1YPEG = 0.49
Guidance for 2018 is adjusted EPS of $8.70-8.90 on Slide 15.
Presentation for the quarter/full-year 2017:
http://files.shareholder.com/downloads/AMDA-262QUJ/594258069…
Quarterly Announcement Press Release:
http://files.shareholder.com/downloads/AMDA-262QUJ/594258069…
Juno Acquisition Presentation:
http://files.shareholder.com/downloads/AMDA-262QUJ/594258069…
Release associated with debt offering for Juno Acquisition:
http://ir.celgene.com/releasedetail.cfm?ReleaseID=1057020